Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $205.0000 (-2.4%) ($205.0000 - $215.0000) on Thu. Jun. 10, 2010. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.81% (three month average) | RSI | 35 | Latest Price | $205.0000(-2.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -3.6% a day on average for past five trading days. | Weekly Trend | CAPR declines -4.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(4%) IWM(3%) XOP(3%) EWI(2%) EWP(2%) | Factors Impacting CAPR price | CAPR will decline at least -2.905% in a week (0% probabilities). IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) VWO(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.905% (StdDev 5.81%) | Hourly BBV | 0 () | Intraday Trend | -4.7% | | | |
|
Resistance Level | $242.5 | 5 Day Moving Average | $217.02(-5.54%) | 10 Day Moving Average | $228.16(-10.15%) | 20 Day Moving Average | $242.5(-15.46%) | To recent high | -65.3% | To recent low | 0% | Market Cap | $4.038b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |